COLONIAL MANAGEMENT GROUP, L.P.

Colonial Management Group, L.P. specializes in delivering medication-assisted treatment (MAT) services within federally funded opioid treatment programs, focusing on outpatient mental health and substance abuse care. Their technical expertise centers on implementing evidence-based clinical protocols for opioid use disorder, including the administration of FDA-approved pharmacotherapies such as methadone, buprenorphine, and naltrexone, alongside behavioral health counseling and case management. The contractor demonstrates a focused specialization in operating compliant, high-acuity outpatient treatment centers that meet SAMHSA and DEA regulatory standards for Opioid Treatment Programs (OTPs). Their key differentiator lies in the integration of clinical operations with federal compliance frameworks, ensuring continuity of care for vulnerable populations under strict oversight. The contractor has established a direct working relationship with the Department of Justice, providing critical behavioral health services as part of federal efforts to combat the opioid epidemic. This engagement suggests alignment with DOJ’s Bureau of Prisons or Office of Justice Programs initiatives aimed at reducing recidivism through addiction treatment in correctional and community-based settings. The nature of the award indicates a partnership focused on public safety, harm reduction, and reentry support. Their primary industry focus is NAICS 621420, which encompasses outpatient mental health and substance abuse centers, particularly those operating under federal grants or contracts to deliver MAT services. This positions them as a niche provider in the behavioral health infrastructure space, serving high-need populations in federally designated treatment zones. Colonial Management Group, L.P. is structured as a limited partnership based in Maitland, Florida, with no publicly listed federal certifications. They maintain a targeted geographic footprint aligned with federal treatment site requirements, operating with a lean, mission-driven model focused exclusively on opioid disorder intervention services.